OTHARIS

BridgeBio Pharma, Inc.

BBIO · Nasdaq · US

USD 75.46 +0.68% today

As of Nov 02, 2026 20:45 UTC — not a live feed

52-week range
USD 60.22 lowat 46% of its rangehigh 93.42
Market Cap
14.8B USD
Sector
Healthcare
Industry
Biotechnology

BridgeBio Pharma, Inc. (BBIO) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. At USD 75.46 it trades at 46% of its 52-week range (USD 60.22 – 93.42).

Otharis Plus · ProAnalysed Nov 02, 2026 from its filings

Is BridgeBio Pharma worth more than its price — and is its growth accelerating?

Two complete methods, run on BBIO's own numbers: Benjamin Graham's value test and the Otharis Growth Score. Every number is real and computed — never estimated.

Value Investing · Benjamin Graham7 criteria · value vs price · margin of safety
  • Size
  • Financial strength
  • Earnings stability
  • Dividend record
  • Earnings growth
  • Moderate P/E
  • Moderate price-to-book
Growth Investing · Otharis Growth Score7 criteria · speed · acceleration · margins
  • Revenue growth
  • Acceleration
  • EPS growth
  • Latest quarter
  • Margin expansion
  • Growth efficiency
  • Price momentum

The verdict, the values and every number behind them are inside Otharis.

✨

Otharis Research Free

A real, deterministic 22-section research report for BBIO - every line tagged FACT, MODEL OUTPUT, ASSUMPTION, ESTIMATE or RULE-BASED INTERPRETATION. 2 reports a day with a free account.

Unlock BBIO’s full analysis →

Start with a free account · Value & Growth analysis included in Otharis Plus and Pro